TRAM1L1
gene geneOn this page
Also known as MGC26568
Summary
TRAM1L1 (translocation associated membrane protein 1 like 1, HGNC:28371) is a protein-coding gene on chromosome 4q26, encoding Translocating chain-associated membrane protein 1-like 1 (Q8N609). Stimulatory or required for the translocation of secretory proteins across the ER membrane.
Predicted to be involved in protein insertion into ER membrane. Predicted to be located in endoplasmic reticulum and membrane. Predicted to be active in endoplasmic reticulum membrane.
Source: NCBI Gene 133022 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 50 total
- MANE Select transcript:
NM_152402
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28371 |
| Approved symbol | TRAM1L1 |
| Name | translocation associated membrane protein 1 like 1 |
| Location | 4q26 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC26568 |
| Ensembl gene | ENSG00000174599 |
| Ensembl biotype | protein_coding |
| OMIM | 617505 |
| Entrez | 133022 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000310754
RefSeq mRNA: 1 — MANE Select: NM_152402
NM_152402
CCDS: CCDS3707
Canonical transcript exons
ENST00000310754 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001201956 | 117083554 | 117085576 |
Expression profiles
Bgee: expression breadth ubiquitous, 210 present calls, max score 87.78.
FANTOM5 (CAGE): breadth broad, TPM avg 2.1095 / max 57.4145, expressed in 823 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 53722 | 1.2580 | 589 |
| 53721 | 0.8515 | 482 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 87.78 | gold quality |
| upper arm skin | UBERON:0004263 | 86.79 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 86.04 | silver quality |
| kidney epithelium | UBERON:0004819 | 85.22 | silver quality |
| corpus epididymis | UBERON:0004359 | 84.25 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.69 | gold quality |
| oviduct epithelium | UBERON:0004804 | 82.26 | gold quality |
| pons | UBERON:0000988 | 81.65 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 81.33 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 81.23 | gold quality |
| cortical plate | UBERON:0005343 | 80.77 | gold quality |
| corpus callosum | UBERON:0002336 | 79.82 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 79.46 | gold quality |
| pancreatic ductal cell | CL:0002079 | 79.31 | silver quality |
| germinal epithelium of ovary | UBERON:0001304 | 78.92 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 78.79 | gold quality |
| retina | UBERON:0000966 | 78.77 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 78.28 | gold quality |
| metanephros | UBERON:0000081 | 78.19 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 77.86 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 77.77 | gold quality |
| prefrontal cortex | UBERON:0000451 | 77.55 | gold quality |
| spinal cord | UBERON:0002240 | 77.50 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 77.42 | gold quality |
| renal medulla | UBERON:0000362 | 77.39 | gold quality |
| substantia nigra | UBERON:0002038 | 76.86 | gold quality |
| midbrain | UBERON:0001891 | 76.80 | gold quality |
| putamen | UBERON:0001874 | 76.72 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.64 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 76.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
73 targeting TRAM1L1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tram1 | ENSDARG00000019137 |
| mus_musculus | Tram1l1 | ENSMUSG00000044528 |
| rattus_norvegicus | Tram1l1 | ENSRNOG00000087014 |
| drosophila_melanogaster | TRAM | FBGN0040340 |
| caenorhabditis_elegans | WBGENE00007696 |
Paralogs (2): TRAM2 (ENSG00000065308), TRAM1 (ENSG00000067167)
Protein
Protein identifiers
Translocating chain-associated membrane protein 1-like 1 — Q8N609 (reviewed: Q8N609)
All UniProt accessions (1): Q8N609
UniProt curated annotations — full annotation on UniProt →
Function. Stimulatory or required for the translocation of secretory proteins across the ER membrane.
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the TRAM family.
RefSeq proteins (1): NP_689615* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006634 | TLC-dom | Domain |
| IPR016447 | Translocation_assoc_membrane | Family |
Pfam: PF03798
UniProt features (23 total): topological domain 9, transmembrane region 8, sequence conflict 2, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N609-F1 | 80.64 | 0.39 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 64 (showing top):
TGCGCANK_UNKNOWN, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_PROTEIN_TARGETING, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_PROTEIN_TARGETING_TO_MEMBRANE, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT, GOBP_MEMBRANE_ORGANIZATION, GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION, GOBP_LOCALIZATION_WITHIN_MEMBRANE, GOBP_PROTEIN_INSERTION_INTO_MEMBRANE, GOBP_TRANSMEMBRANE_TRANSPORT
GO Biological Process (3): SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616), protein insertion into ER membrane (GO:0045048), protein transport (GO:0015031)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| SRP-dependent cotranslational protein targeting to membrane | 1 |
| intracellular protein transmembrane transport | 1 |
| endoplasmic reticulum organization | 1 |
| protein localization to organelle | 1 |
| protein insertion into membrane | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
360 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRAM1L1 | NDST4 | Q9H3R1 | 447 |
| TRAM1L1 | KLHL8 | Q9P2G9 | 446 |
| TRAM1L1 | TLCD1 | Q96CP7 | 435 |
| TRAM1L1 | CCDC47 | Q96A33 | 407 |
| TRAM1L1 | POM121L2 | Q96KW2 | 398 |
| TRAM1L1 | NKAIN3 | Q8N8D7 | 380 |
| TRAM1L1 | NDST3 | O95803 | 379 |
| TRAM1L1 | FAM174A | Q8TBP5 | 379 |
| TRAM1L1 | QRFPR | Q96P65 | 372 |
| TRAM1L1 | TM4SF20 | Q53R12 | 371 |
| TRAM1L1 | H2AL3 | A0A3B3IU63 | 370 |
| TRAM1L1 | RUNDC3B | Q96NL0 | 365 |
| TRAM1L1 | ZFP28 | Q8NHY6 | 351 |
| TRAM1L1 | ZNF804B | A4D1E1 | 348 |
| TRAM1L1 | SEC63 | Q9UGP8 | 348 |
IntAct
80 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRAM1L1 | CD99L2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | MUC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | EVI2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | MFF | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | CLEC1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | TMEM79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BSCL2 | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | LRRC59 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASGR2 | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MUC1 | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | ERGIC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | PLEKHF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CD53 | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | CLSTN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | FKBP7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CD79A | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHO1 | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | CYBC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | GPX8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAM1L1 | CREB3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM209A | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM52B | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EVI2B | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLPP2 | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (30): TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid), TRAM1L1 (Two-hybrid)
ESM2 similar proteins: A2AKM2, A4FUY9, A5D6V4, A7YY55, A8WGS4, Q01685, Q0P5C7, Q15629, Q3T124, Q4R8A8, Q4V8U5, Q5BJF2, Q5GH60, Q5GH61, Q5GH68, Q5HZE5, Q5ND56, Q5NVQ2, Q5R7Z3, Q5U2T1, Q5VWC8, Q5XI41, Q5ZM57, Q60457, Q6DED0, Q6GLX2, Q6GNB5, Q6P4N1, Q6PP77, Q6YWS8, Q7SY06, Q84QC0, Q86X19, Q8CGF5, Q8K0U3, Q8K2C9, Q8N609, Q8QZR0, Q8R000, Q8VZB2
Diamond homologs: Q01685, Q15035, Q15629, Q5E9R6, Q5R7Z3, Q5XI41, Q6DED0, Q8N609, Q8QZR0, Q91V04, Q924Z5, Q9GKZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
149 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:117084577:C:T | acceptor_gain | 0.6500 |
| 4:117085415:A:AC | donor_gain | 0.5700 |
| 4:117085416:C:CC | donor_gain | 0.5700 |
| 4:117085408:GATAC:G | donor_loss | 0.5600 |
| 4:117085409:ATACT:A | donor_loss | 0.5600 |
| 4:117085410:TACT:T | donor_loss | 0.5600 |
| 4:117085411:ACT:A | donor_loss | 0.5600 |
| 4:117085412:CT:C | donor_loss | 0.5600 |
| 4:117085413:T:TC | donor_loss | 0.5600 |
| 4:117085414:C:CC | donor_loss | 0.5600 |
| 4:117085416:C:CA | donor_loss | 0.5600 |
| 4:117085021:A:C | donor_gain | 0.5400 |
| 4:117085326:TGATT:T | acceptor_gain | 0.5400 |
| 4:117085331:C:CC | acceptor_gain | 0.5300 |
| 4:117085416:CCGG:C | donor_gain | 0.5200 |
| 4:117085329:TT:T | acceptor_gain | 0.4900 |
| 4:117084578:A:T | acceptor_gain | 0.4600 |
| 4:117085407:GGATA:G | donor_loss | 0.4400 |
| 4:117085096:ATT:A | donor_gain | 0.4200 |
| 4:117084566:CAGG:C | acceptor_gain | 0.4100 |
| 4:117084842:G:C | acceptor_gain | 0.4000 |
| 4:117085227:CTGTG:C | acceptor_gain | 0.3900 |
| 4:117085328:ATT:A | acceptor_loss | 0.3900 |
| 4:117085329:TTC:T | acceptor_loss | 0.3900 |
| 4:117085330:TCTGC:T | acceptor_loss | 0.3900 |
| 4:117085331:C:A | acceptor_loss | 0.3900 |
| 4:117085332:TG:T | acceptor_loss | 0.3900 |
| 4:117085333:G:C | acceptor_loss | 0.3800 |
| 4:117085334:CAGGA:C | acceptor_loss | 0.3800 |
| 4:117085338:A:C | acceptor_loss | 0.3800 |
AlphaMissense
2431 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:117084482:A:C | S304R | 0.993 |
| 4:117084482:A:T | S304R | 0.993 |
| 4:117084484:T:G | S304R | 0.993 |
| 4:117084988:C:G | G136R | 0.986 |
| 4:117085158:T:G | D79A | 0.986 |
| 4:117085159:C:G | D79H | 0.985 |
| 4:117084481:A:G | C305R | 0.983 |
| 4:117084896:C:A | K166N | 0.980 |
| 4:117084896:C:G | K166N | 0.980 |
| 4:117085340:G:C | F18L | 0.980 |
| 4:117085340:G:T | F18L | 0.980 |
| 4:117085342:A:G | F18L | 0.980 |
| 4:117084873:G:T | A174D | 0.974 |
| 4:117084987:C:T | G136D | 0.974 |
| 4:117085158:T:C | D79G | 0.972 |
| 4:117085026:C:T | G123D | 0.971 |
| 4:117085157:A:C | D79E | 0.971 |
| 4:117085157:A:T | D79E | 0.971 |
| 4:117085158:T:A | D79V | 0.971 |
| 4:117084868:A:G | W176R | 0.970 |
| 4:117084868:A:T | W176R | 0.970 |
| 4:117085111:C:G | A95P | 0.970 |
| 4:117084739:C:G | G219R | 0.969 |
| 4:117084739:C:T | G219R | 0.969 |
| 4:117085016:A:C | S126R | 0.969 |
| 4:117085016:A:T | S126R | 0.969 |
| 4:117085018:T:G | S126R | 0.969 |
| 4:117084498:G:T | A299D | 0.968 |
| 4:117084783:A:G | L204P | 0.967 |
| 4:117084898:T:C | K166E | 0.966 |
dbSNP variants (sampled 300 via entrez): RS1000472812 (4:117085781 C>T), RS1000988899 (4:117083991 C>A), RS1001298765 (4:117086696 T>C), RS1001718299 (4:117083310 A>G), RS1002252107 (4:117085614 G>A,C), RS1002324448 (4:117085005 A>C), RS1002678497 (4:117085377 T>C,G), RS1003264873 (4:117086615 A>T), RS1005818862 (4:117086222 G>A), RS1006181139 (4:117086542 C>A,G), RS1006401887 (4:117084534 A>C), RS1006798448 (4:117084159 G>C), RS1007388812 (4:117085648 G>A,T), RS1007916962 (4:117085868 T>A), RS1007926107 (4:117084054 A>G)
Disease associations
OMIM: gene MIM:617505 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000426_7 | Obesity (extreme) | 3.000000e-06 |
| GCST001523_43 | Visceral adipose tissue adjusted for BMI | 8.000000e-06 |
| GCST002104_19 | Bronchopulmonary dysplasia | 1.000000e-06 |
| GCST003830_43 | Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1) | 7.000000e-07 |
| GCST005286_1 | Lateral ventricle volume in trauma-exposed individuals | 2.000000e-07 |
| GCST009391_1184 | Metabolite levels | 9.000000e-06 |
| GCST011767_7 | Bipolar disorder | 5.000000e-09 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0005921 | FEV change measurement |
| EFO:0008483 | response to trauma exposure |
| EFO:0008487 | lateral ventricle volume measurement |
| EFO:0010454 | adenosine monophosphate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects expression, decreases methylation | 5 |
| Air Pollutants | decreases expression, increases abundance | 2 |
| Nickel | decreases expression | 2 |
| Particulate Matter | decreases expression, increases abundance | 2 |
| aristolochic acid I | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| methylparaben | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| pentabromodiphenyl ether | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Malathion | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression, increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Smoke | increases expression | 1 |
| Thiram | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): bronchopulmonary dysplasia